Indian Association of Blood Cancer & Allied Diseases connects scientists from across various cancer research institutes globally to understand the common underlying causes of cancer, wherever it appears. Traditional cancer research continues to focus on vital questions about the treatment and care of specific types of cancer. Complementing this work, today’s research also seeks to understand core cellular and molecular links across multiple cancers. The purpose of the Cancer Research is to study this core biology.
IABCD Board members are committed to building an institute for the long term and with a clear emphasis on making their research count for cancer.
Research endeavours at IABCD Blood Centre are focused to explore advanced research results and communicate stakeholders through a variety of disciplines: Developmental Therapeutics, Genetics, Cancer Immunology, Cancer , Prevention & Control, and Genome Integrity.
Developmental Therapeutics (DT) Research Program is a critical translational innovation initiative, bridging drug discovery and experimental therapeutics to translate preclinical discoveries and treatment strategies into the clinic, while returning clinical advances to the bench for refinement.
The mission of the Genomics, Genetics and Epigenetics Programme study all aspects of gene alterations in cancer with the goal of translating this knowledge into new drugs, novel therapeutic strategies, and novel diagnostic tests. These studies include the discovery of mutations in genes and DNA that cause cancer; analysis of genomic changes and their functional consequences on gene expression; characterization of mechanisms that control protein production from genes; epigenetics; protein structure; and the analysis of large scale genomic data.
Cancer Immunology (CI) Research Programme is to improve understanding of the host response to cancer and to discover and test novel approaches to harness that response to improve patient outcomes. Immune checkpoint blockade for cancer treatment has emerged as one of the most exciting and promising new approaches to treat cancer in decades. The goals of the Cancer Immunology Program are to:

  • Identify the mechanisms underlying the capacity of the immune system to inhibit tumour growth, as well as mechanisms that drive tumour immune resistance.
  • Discover and test new approaches for promoting anti-tumour immunity.
  • Study the mechanistic links between inflammation and cancer.
  • Undertake targeted therapeutic trials that utilize novel endpoint assessment

The mission of the Cancer Prevention and Control Programme is to prevent and control cancer by identifying factors that contribute to cancer development and outcomes, and conducting interventions to address these factors. It has been recognized for many years that cancer risk is determined by the interaction of lifestyle factors and genetics. Identifying lifestyle factors such as tobacco use and excess body weight that contribute to cancer and intervening appropriately has been proven to significantly impact on the cancer burden.
Physicians and Researchers all striving to conduct cutting-edge research to identify the causes of human cancers, and use behavioural and other approaches to translate findings into public health interventions to reduce cancer incidence, cancer morbidity, and mortality.
The goals of the Cancer Prevention and Control Programme are to:

  •  Identify lifestyle, environmental, and genetic risk factors in the aetiology of cancer
  • Assess the patterns of care received by patients with cancer to identify effective strategies to improve patient outcomes
  • Conduct and evaluate lifestyle behavioural interventions for cancer prevention and control.